Ureteric stents in pyeloplasty: a help or a hindrance?
Abstract
Objective
To examine whether routine ureteric stenting influences outcome of pyeloplasty for pelvi-ureteric junction obstruction (PUJO).
Patients and methods
A 10-year review was conducted of 105 consecutive open Anderson–Hynes dismembered pyeloplasties performed for PUJO, covering two periods: (1) pyeloplasties performed without ureteric stents (1994–1998) and (2) pyeloplasties performed with ureteric stents (1999–2003). Outcomes (expressed as means
±
SEM) of unstented patients (UPs; n
=
47) and stented patients (SPs; n
=
58) were compared and results analysed using ANOVA and chi-square tests.
Results
Fifty-five patients (53.9%) presented with antenatal hydronephrosis, whilst 47 (46.1%) presented postnatally (at mean age 88.4
±
7.1
months) with one or more of the following: pain (n
=
30, 63.8%), urinary tract infection (n
=
16; 34.0%), haematuria (n
=
3, 6.4%), abdominal mass (n
=
3, 6.4%), acute renal failure (n
=
2, 4.3%), incidental finding (n
=
4, 8.5%). Pyeloplasty was performed (at mean age 58.9
±
5.3
months) for one or more of the following: pain (n
=
40, 38.1%), haematuria (n
=
6, 5.7%), urinary tract infection (n
=
18, 17.1%), poor initial or deteriorating function (n
=
29, 27.6%), severe or deteriorating hydronephrosis (n
=
41, 39.0%), calculus (n
=
1, 0.95%). Recognised complications of surgery were significantly higher in UPs (5 of 47; 10.6%) than SPs (0 of 58); P
=
0.016. These were leakage (n
=
4, 8.5%) and obstruction by blood clot (n
=
1, 2.1%). Nine SPs (15.5%) developed stent-related complications, including stent migration (n
=
5, 8.6%), infection (n
=
3, 5.2%) and calculus (n
=
1, 1.7%). SPs had significantly shorter hospital stay (2.71
±
0.25
days) than UPs (4.30
±
0.38 days); P
<
0.01. Preoperative renal pelvis antero-posterior diameter in SPs (3.24
±
0.25
cm) and UPs (3.21
±
0.28
cm) was comparable (P
=
0.80). Following pyeloplasty, a significant improvement from these preoperative baselines occurred earlier in SPs (at 3.10
±
0.46
months) than UPs (at 15.71
±
3.05
months); P
<
0.01.
Conclusion
Stented pyeloplasty significantly reduces complications from surgery, particularly leakage, and results in shorter hospital stay and earlier resolution of hydronephrosis, but at the expense of stent-related complications which could be avoided in future by the use of external stents.
Keywords: Anderson–Hynes, Unstented patients, Stented patients, Pelvi-ureteric junction obstruction
To access this article, please choose from the options below
PII: S1477-5131(08)00211-8
doi:10.1016/j.jpurol.2008.01.205
© 2008 Journal of Pediatric Urology Company. Published by Elsevier Inc. All rights reserved.
